
Hantavirus vaccine in 2026?

Jan 1, 2027
$153.98K Vol.

End date: Jan 1, 2027

Hantavirus vaccine in 2026?
$153.98K Vol.
1%
1%
Rules
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Comments (7)
Comments (7)
Hantavirus vaccine in 2026?

$153.98K Vol.
1%